BioMarin Pharmaceutical Inc. (BMV:BMRN)

The Shyft Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,214	942.84	755.13	724.53	587.28	649.16
Short-Term Investments	218.31	194.86	318.68	567.01	426.6	416.23
Cash & Short-Term Investments	1,432	1,138	1,074	1,292	1,014	1,065
Cash Growth	16.97%	5.95%	-16.86%	27.39%	-4.83%	41.33%
Accounts Receivable	855.86	660.54	633.7	461.32	373.4	448.35
Receivables	855.86	660.54	633.7	461.32	373.4	448.35
Inventory	1,340	1,233	1,107	894.08	776.67	698.55
Other Current Assets	177.18	201.53	141.39	104.52	110.44	129.93
Total Current Assets	3,805	3,232	2,956	2,751	2,274	2,342
Property, Plant & Equipment	1,030	1,077	1,112	1,114	1,082	1,090
Long-Term Investments	508.59	527.84	622.44	370.34	524.29	295.97
Goodwill	196.2	196.2	196.2	196.2	196.2	196.2
Other Intangible Assets	239.62	327.38	325.3	338.57	388.65	417.27
Long-Term Deferred Tax Assets	1,427	1,489	1,546	1,505	1,450	1,432
Other Long-Term Assets	249.19	138.94	83.56	98.78	89.2	74.63
Total Assets	7,456	6,989	6,842	6,375	6,005	5,848
Accounts Payable	310.8	235.4	315.51	231.24	199.68	191.43
Accrued Expenses	290.59	331.27	311.55	293.53	267.65	257.27
Current Portion of Long-Term Debt	-	-	493.88	-	-	-
Current Portion of Leases	7.7	7.57	8.78	10.38	10.46	11.75
Current Income Taxes Payable	13.4	12.57	2.65	16.21	1.21	9.66
Current Unearned Revenue	-	1.37	4.62	0.71	6.96	0.15
Other Current Liabilities	61.76	18.8	40.04	36.81	60.54	22.29
Total Current Liabilities	684.25	606.99	1,177	588.88	546.5	492.55
Long-Term Debt	596.16	595.14	593.1	1,083	1,079	1,075
Long-Term Leases	-	31.26	38.12	26.51	33.84	44.49
Other Long-Term Liabilities	148.82	97.57	81.81	73.5	79.69	129.84
Total Liabilities	1,429	1,331	1,890	1,772	1,739	1,742
Common Stock	0.19	0.19	0.19	0.19	0.18	0.18
Additional Paid-In Capital	5,852	5,802	5,612	5,405	5,192	4,993
Retained Earnings	231.52	-194.7	-621.55	-789.2	-930.76	-861.61
Comprehensive Income & Other	-56.24	50.43	-38.65	-12.73	4.74	-25.98
Shareholders' Equity	6,027	5,658	4,952	4,603	4,266	4,106
Total Liabilities & Equity	7,456	6,989	6,842	6,375	6,005	5,848
Total Debt	603.87	633.97	1,134	1,120	1,123	1,131
Net Cash (Debt)	828.26	503.74	-60.07	171.63	-109.51	-66
Net Cash Growth	564.15%	-	-	-	-	-
Net Cash Per Share	4.25	2.56	-0.31	0.91	-0.60	-0.34
Filing Date Shares Outstanding	192.01	190.78	188.68	186.53	184.03	181.83
Total Common Shares Outstanding	192	190.76	188.6	186.25	183.91	181.74
Working Capital	3,121	2,625	1,779	2,163	1,728	1,850
Book Value Per Share	31.39	29.66	26.25	24.71	23.19	22.59
Tangible Book Value	5,591	5,134	4,430	4,068	3,681	3,493
Tangible Book Value Per Share	29.12	26.92	23.49	21.84	20.01	19.22
Land	-	90.78	90.78	90.79	90.42	90.42
Buildings	-	892.48	860.81	819.1	774.92	761.56
Machinery	-	789.5	796.61	736.25	688.54	644.4
Construction In Progress	-	90.27	100.01	143.38	136.74	109.14
Leasehold Improvements	-	44.37	58.23	59.53	55.28	55.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.